SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta-analysis of randomized clinical trials.
Oates CP, Santos-Gallego CG, Smith A, Basyal B, Moss N, Kawamura I, Musikantow DR, Turagam MK, Miller MA, Whang W, Dukkipati SR, Reddy VY, Koruth JS.
Oates CP, et al. Among authors: miller ma.
J Cardiovasc Electrophysiol. 2023 May;34(5):1277-1285. doi: 10.1111/jce.15894. Epub 2023 Mar 31.
J Cardiovasc Electrophysiol. 2023.
PMID: 36950852